Alpha Healthcare Acquisition Corp. Unit
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch AHACU and buy or sell other stocks, ETFs, and their options commission-free!About AHACU
Humacyte, Inc. engages in the business of developing and manufacturing off-the-shelf, universally implantable, bioengineered human tissues, advanced tissue constructs, and organ systems with the goal of improving the lives of patients and transforming the practice of medicine. The company was founded by Laura E.
CEOLaura E. Niklason, MD, PhD
CEOLaura E. Niklason, MD, PhD
Employees220
Employees220
HeadquartersDurham, North Carolina
HeadquartersDurham, North Carolina
Founded2004
Founded2004
Employees220
Employees220
AHACU Key Statistics
Market cap1.92B
Market cap1.92B
Price-Earnings ratio-35.75
Price-Earnings ratio-35.75
Dividend yield—
Dividend yield—
Average volume4.14K
Average volume4.14K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$20.23
52 Week high$20.23
52 Week low$9.83
52 Week low$9.83
Stock Snapshot
Alpha Healthcare Acquisition Corp. Unit(AHACU) stock is priced at $12.08, giving the company a market capitalization of 1.92B. It carries a P/E multiple of -35.75.
On 2025-12-14, Alpha Healthcare Acquisition Corp. Unit(AHACU) shares started trading at —, with intraday highs of — and lows of —.
Trading volume for Alpha Healthcare Acquisition Corp. Unit(AHACU) stock has reached 0, versus its average volume of 4.14K.
Over the past 52 weeks, Alpha Healthcare Acquisition Corp. Unit(AHACU) stock has traded between a high of $20.23 and a low of $9.83.
Over the past 52 weeks, Alpha Healthcare Acquisition Corp. Unit(AHACU) stock has traded between a high of $20.23 and a low of $9.83.